BLTE Stock Analysis: Buy, Sell, or Hold?
BLTE - Belite Bio, Inc American Depositary Shares
$146.68
-0.35 (-0.24%)
▼
5d:
-6.98%
30d:
+7.18%
90d:
-15.3%
HOLD
LOW Confidence
Analysis Updated: Jul 14, 2026 12:00 AM ET
Earnings: Aug 10, 2026
26d
Get Alerted When BLTE Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: BLTE shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
📊 HOLD: BLTE shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$33.08
Based on 7.0% avg growth
INTRINSIC VALUE TODAY
$20.54
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 25.0x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: BLTE is currently trading at $146.68, which is considered fair relative to its 30-day fair value range of $140.85 to $152.40. From a valuation perspective, the stock is trading at a discount (Forward PE: 155.3) compared to its historical average (181.6). Remarkably, the market is currently pricing in an annual earnings decline of 5.1% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, BLTE is in a strong downtrend. Immediate support is located at $140.99, while resistance sits at $158.90.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $210.50 (+43.5%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, BLTE is in a strong downtrend. Immediate support is located at $140.99, while resistance sits at $158.90.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $210.50 (+43.5%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$140.85 -
$152.40
Company Quality Score
57/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
72.4%
All Signals
- NEUTRAL: Price in fair range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 43.5% below Wall St target ($210.50)
- CAUTION: Recommendation downgraded due to -7.0% 5-day decline
Trading Range Analysis
30-Day Trading Range
$140.85 -
$152.40
Current vs Trading Range
FAIR
Support & Resistance Levels
Support Level
$140.99
Resistance Level
$158.90
Current Trend
Strong Downtrend
Technical data as of
Jul 14, 2026
Fundamental Context
Forward P/E (Next Year Est.)
155.33
Wall Street Target
$210.50
(+43.5%)
Valuation Discount vs History
-5.1% cheaper
PE vs Historical
155.3 vs 181.6
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-5.1%
(market-implied from PE analysis)
1-Year Target
$139.20
(-5%)
2-Year Target
$132.10
(-10%)
3-Year Target
$125.36
(-15%)
3-Yr Target (if PE normalizes)
(PE: 155→182)
$146.56
(0%)
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 155.3 to 181.6
Stabilization Target:
$171.48
(+16.9%)
PE Expansion Potential:
+16.9%
Share & Embed Analysis
Last updated: July 14, 2026 5:20 PM ET
Data refreshes hourly during market hours. Next update: 6:20 PM
Data refreshes hourly during market hours. Next update: 6:20 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is BLTE showing a specific setup today?
Insider Activity (6 Months)
0
Buys
7
Sells
Net
INSIDERS SELLING
Recent Transactions
Nathan L Mata
SELL
1000 shares
2026-04-22
Nathan L Mata
SELL
1000 shares
2026-04-20
Nathan L Mata
SELL
1000 shares
2026-04-17
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BMRN
Biomarin Pharmaceutical … |
STRONG BUY
29 analysts |
$88 | 65 BUY |
|
ARGX
argenx NV ADR |
STRONG BUY
22 analysts |
$1051 | 52 HOLD |
|
CRSP
Crispr Therapeutics AG |
BUY
28 analysts |
$85 | 50 HOLD |
|
DNLI
Denali Therapeutics Inc |
STRONG BUY
19 analysts |
$34 | 55 HOLD |
|
KYMR
Kymera Therapeutics Inc |
STRONG BUY
20 analysts |
$124 | 58 HOLD |
